Table 2 Outcomes

Duration surgery, median [IQR], min

169 [102 to 218]

94 [62 to 143]

198 [168 to 244]

142 [86 to 186]

203 [177 to 250]

 < 0.0001

Stay inhouse, median [IQR], days

11 [7 to 16]

7 [4 to 11]

12 [10 to 18]

12 [8 to 19]

12 [9 to 17]

 < 0.0001

Stay ICU, mean [SD], days

1.5 [2.8]

0.5 [1.7]

1.9 [3.6]

2.0 [2.8]

2.1 [2.8]

 < 0.0001

 Unknown

9 (2.3%)

9 (7.1%)

–

–

 –

Complication Clavien–Dindo

 None

253 (65.0%)

105 (82.7%)

55 (59.8%)

36 (55.4%)

57 (54.3%)

0.004

 I

26 (6.7%)

5 (3.9%)

7 (7.6%)

7 (10.8%)

7 (6.7%)

 II

46 (11.8%)

8 (6.3%)

13 (14.1%)

9 (13.8%)

16 (15.2%)

 IIIa

22 (5.7%)

5 (3.9%)

5 (5.4%)

5 (7.7%)

7 (6.7%)

 IIIb

20 (5.1%)

3 (2.4%)

5 (5.4%)

3 (4.6%)

9 (8.6%)

 IVa

6 (1.5%)

–

4 (4.3%)

–

2 (1.9%)

 IVb

–

–

–

–

–

 V

16 (4.1%)

1 (0.8%)

3 (3.3%)

5 (7.7%)

7 (6.7%)

Complication

 None

253 (65.0%)

105 (82.7%)

55 (59.8%)

36 (55.4%)

57 (54.3%)

0.0001

 Minor (Clavien–Dindo < IIIa)

72 (18.5%)

13 (10.2%)

20 (21.7%)

16 (24.6%)

23 (21.9%)

 Major (Clavien–Dindo ≥ IIIa)

64 (16.5%)

9 (7.1%)

17 (18.5%)

13 (20.0%)

25 (23.8%)

30-day mortality rate

19 (4.9%)

3 (2.4%)

3 (3.3%)

7 (10.8%)

6 (5.7%)

0.075

30-day readmission rate

 Readmission

31 (8.0%)

8 (6.3%)

8 (8.7%)

7 (10.8%)

8 (7.6%)

0.886

 No readmission

336 (86.4%)

97 (76.4%)

84 (91.3%)

58 (89.2%)

97 (92.4%)

 Unknown

22 (5.7%)

22 (17.3%)

–

–

–

Recommendation of CTx

 Yes

328 (84.3%)

106 (83.5%)

79 (85.9%)

54 (83.1%)

89 (84.8%)

0.919

 No

34 (8.7%)

10 (7.9%)

10 (10.9%)

5 (7.7%)

9 (8.6%)

 Unknown

27 (6.9%)

11 (8.7%)

3 (3.3%)

6 (9.2%)

7 (6.7%)

Starting CTx after recommendation

 Yes

123/328 (37.5%)

63/106 (59.4%)

24/79 (30.4%)

14/54 (25.9%)

22/89 (24.7%)

0.731

 No

50/328 (15.2%)

21/106 (19.8%)

12/79 (15.2%)

6/54 (11.1%)

11/89 (12.4%)

 Unknown

155/328 (47.3%)

22/106 (20.8%)

43/79 (54.4%)

34/54 (63.0%)

56/89 (62.9%)